Penelope Linda Moore

Title: Penelope Linda Moore: Innovator in HIV-1 Research

Introduction

Penelope Linda Moore is a distinguished inventor based in Modderfontein, South Africa. She has made significant contributions to the field of anti-HIV therapies, particularly through her innovative research on broadly neutralizing monoclonal antibodies.

Latest Patents

Moore holds a patent for "Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region." This invention relates to anti-HIV therapies and prophylaxis. Specifically, it focuses on broadly neutralizing antibodies against HIV-1, nucleic acids encoding these antibodies, vectors comprising the nucleic acids, and cells and pharmaceutical compositions that include said vectors and/or antibodies. The invention also encompasses the use of these antibodies and/or vectors for the treatment and/or prevention of HIV-1 infection in a subject. Furthermore, it includes a kit containing the antibodies of the invention.

Career Highlights

Throughout her career, Penelope Linda Moore has worked with notable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and Columbia University. Her work has been pivotal in advancing the understanding and treatment of HIV-1.

Collaborations

Moore has collaborated with esteemed colleagues such as Chaim Aryeh Schramm and Jason Gorman, contributing to the collective effort in HIV research and therapy development.

Conclusion

Penelope Linda Moore's innovative work in the field of HIV-1 research highlights her commitment to improving health outcomes through scientific advancements. Her contributions continue to pave the way for future developments in anti-HIV therapies.